← Back to Search

Aromatherapy for Substance Use Disorder

N/A
Recruiting
Led By Marian Reven, PhD
Research Sponsored by West Virginia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All participants must be alert and oriented
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 18 months
Awards & highlights

Study Summary

This trial explores whether Bergamot essential oil can reduce comfort, ease and stress in adults. Participants use an inhaler 3x/day for one week, then report their stress levels. Logging use of the inhaler also required.

Who is the study for?
This trial is for adults in a Substance Use Disorder treatment program who are alert, oriented, and at any stage of treatment. They must be able to give written consent, read and write English, but cannot participate if they dislike Bergamot or have allergies to citrus or serious respiratory diseases like asthma.Check my eligibility
What is being tested?
The study tests whether Bergamot essential oil can help with comfort, ease, and stress when used three times daily for one week. Participants will use an aroma inhaler and keep a daily logbook while their feelings of comfort and stress are surveyed before and after the trial period.See study design
What are the potential side effects?
Potential side effects may include discomfort from the scent if not liked by the participant. Those with citrus allergies might experience allergic reactions. Individuals with respiratory conditions such as asthma could potentially have exacerbated symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am mentally alert and aware of who I am, where I am, and the current time.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Examine Acceptability of the intervention
Examine Feasibility (participant enrollment)
Examine Feasibility (participant recruitment)
+2 more
Secondary outcome measures
Change in perceived Comfort level
Change in perceived Ease level
Change in perceived Stress level
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Adults (>18 years) who are currently receiving treatment for SUD in the outpatient treatment program at West Virginia University Chestnut Ridge Center (WVUCRC) (n = 340 approx.). In addition, participants can be at any level of treatment, including peer recovery coach program. Inclusion criteria are patients diagnosed with SUD who have completed intensive acute phase 1 treatment, and who desire to pursue continuous recovery phases (per facility protocol). All participants must be alert and oriented, provide written consent, and be able to read and write English. Exclusion criteria are patients diagnosed with severe mental illness (who cannot consent to participate), have a medical history of asthma or other serious respiratory disease, and known allergy to citrus.
Group II: Control GroupActive Control1 Intervention
Adults (>18 years) who are currently receiving treatment for SUD in the outpatient treatment program at West Virginia University Chestnut Ridge Center (WVUCRC) (n = 340 approx.). In addition, participants can be at any level of treatment, including peer recovery coach program. Inclusion criteria are patients diagnosed with SUD who have completed intensive acute phase 1 treatment, and who desire to pursue continuous recovery phases (per facility protocol). All participants must be alert and oriented, provide written consent, and be able to read and write English. Exclusion criteria are patients diagnosed with severe mental illness (who cannot consent to participate), have a medical history of asthma or other serious respiratory disease, and known allergy to citrus.

Find a Location

Who is running the clinical trial?

West Virginia UniversityLead Sponsor
174 Previous Clinical Trials
56,083 Total Patients Enrolled
West Virginia Nurses AssociationUNKNOWN
Marian Reven, PhDPrincipal InvestigatorWest Virginia University

Media Library

Intervention Group Clinical Trial Eligibility Overview. Trial Name: NCT05660434 — N/A
Substance Use Disorder Research Study Groups: Intervention Group, Control Group
Substance Use Disorder Clinical Trial 2023: Intervention Group Highlights & Side Effects. Trial Name: NCT05660434 — N/A
Intervention Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05660434 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining opportunities to participate in this clinical trial?

"Clinicaltrials.gov reports that this research is actively searching for candidates, with the first posting of the study appearing on August 23rd 2022 and most recent update occuring in December 20th 2022."

Answered by AI

What is the aggregate sum of participants signing up for this experiment?

"Yes, the information presented on clinicaltrials.gov indicates that this experiment is presently recruiting participants. It was first listed on August 23rd 2022 and has been modified as recently as December 20th 2022. The research needs to find 98 people from 1 site for enrolment."

Answered by AI
~12 spots leftby Jun 2024